With the actions being taken by investment bankers, investors who are seeking to replicate Canada’s success in the cannabis industry may not need to wait longer. In July, Canaccord Genuity Inc., the financial services firm with the most extensive stock offerings for cannabis-related companies, has appointed banker Tristan Gervais to be in the forefront of the firm’s investment plans in Europe.
Bryan Garnier & Co., a French bank, is also taking steps. In the previous year, the bank started coverage on the Canadian sector through an analyst based in Paris. Recently, Jefferies Financial Group Inc. also ushered in coverage on some pot stocks in North America via an analyst based in London.
Sativa Investments (NEX:SATI) is the UK’s first medicinal cannabis investment vehicle. After investing in two North American businesses, it is now progressing a UK seed to consumer investment strategy with 100% ownership of businesses involved in the production, testing and compliance, research & development including pharmacology, commercialisation and sales & marketing of medicinal cannabis and cannabidiol products. Two UK businesses, George Botanicals and PhytoVista Laboratories, are already fully operational.